Aytu BioPharma, Inc. (AYTU) vs Kyntra Bio, Inc. (KYNB)

A side-by-side comparison of Aytu BioPharma, Inc. and Kyntra Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AYTU vs KYNB

growth of $100 · dividends reinvested · last 10y
AYTU -100.0% (-68.9%/yr)KYNB -98.8% (-35.7%/yr)KYNB compounded faster over this window
Log scale — wide-divergence pair
00001101001kStart $10020182020202220242026$0$1
AYTU KYNB

AYTU vs KYNB: by the numbers

  • •KYNB is the larger company ($24M vs $22M market cap).
  • •KYNB is profitable (3967.77% net margin) while AYTU runs a net loss (-24.76%).
  • •Both shrank revenue over the past five years; AYTU's decline was smaller (-2.59% vs -51.49% CAGR).

Metrics side by side

Valuation

MetricAYTUKYNB
P/S ratio0.385.19
P/B ratio0.62N/A
FCF yield14.93%N/A

Profitability

MetricAYTUKYNB
Gross margin63.95%91.37%
Operating margin-14.44%-712.66%
Net margin-24.76%3967.77%
ROE-40.40%N/A
ROIC-14.21%-78.16%

Growth (annualized)

MetricAYTUKYNB
Revenue CAGR (5Y)-2.59%-51.49%
Total return CAGR (5Y)-48.14%-52.67%

Frequently asked

Which has grown faster, AYTU or KYNB?
Neither grew: over the past five years both shrank revenue, with AYTU's decline the smaller — AYTU at a -2.59% CAGR versus KYNB at -51.49%.
Is AYTU or KYNB more profitable?
KYNB runs the higher net margin — AYTU at -24.76% versus KYNB at 3967.77%.
How have AYTU and KYNB total returns compared?
Over the past 10 years, AYTU delivered -68.87% and KYNB delivered -35.88% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.